• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Repligen Corp (NQ: RGEN )

    138.63 -2.16 (-1.53%)
    Streaming Delayed Price Updated: 3:20 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Repligen Corp

    < Previous 1 2 3 4 5 6 Next >
    Stocks That Hit 52-Week Highs On Friday
    Before 10 a.m. ET on Friday, 52 companies hit new 52-week highs. Highlights: Microsoft (NASDAQ:MSFT) was the biggest company by market cap to set a new 52-week high... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Wednesday
    Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs. Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market cap basis to set a new... 
    Via Benzinga
    The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    Stocks That Hit 52-Week Highs On Thursday
    Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new... 
    Via Benzinga
    Tandem Diabetes Care Stock Sees Improved Relative Strength
    The Relative Strength (RS) Rating for Tandem Diabetes Care stock moved up into a higher percentile Monday, as it got a lift from 68 to 73. 
    Via Investor's Business Daily
    The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For July 27, 2021
    Companies Reporting Before The Bell • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on revenue of $146.03 million.... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
    Via Benzinga
    Exposures Product Safety
    Stocks That Hit 52-Week Highs On Tuesday
    Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (... 
    Via Benzinga
    Staar Surgical Stock Scores Relative Strength Rating Upgrade
    Staar Surgical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an increase from 89 to 95. 
    Via Investor's Business Daily
    The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
    Via Benzinga
    The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    Why Repligen Stock Soared This Week
    The life sciences company reported better-than-expected second-quarter results. 
    Via The Motley Fool
    The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures Product Safety
    Is It Too Late to Buy Moderna Stock?
    Moderna Inc. stock skyrocketed last year, moving over 434% on global demand for coronavirus vaccines. The question now is whether it can continue to rally higher, with or without COVID-19. 
    Via Talk Markets
    Exposures COVID-19
    62 Biggest Movers From Yesterday
    Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
    Via Benzinga
    Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
    RGEN earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Recap: Repligen Q2 Earnings
    Shares of Repligen (NASDAQ:RGEN) moved higher by 0.0% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 88.10% over... 
    Via Benzinga
    Earnings Outlook For Repligen
    Repligen (NASDAQ:RGEN) announces its next round of earnings this Tuesday, July 27. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.... 
    Via Benzinga
    3 Healthcare Stocks to Buy and Hold for the Next 10 Years
    Don't overthink it -- buy companies with excellent financials and a long runway for growth. 
    Via The Motley Fool
    Repligen To Buy Polymem For An Undisclosed Sum
    Repligen Corporation (NASDAQ: RGEN) has agreed to acquire France-based Polymem S.A., a provider of hollow fiber membranes and modules. "The acquisition... 
    Via Benzinga
    Repligen Joins Elite List Of Stocks With 95-Plus Composite Rating
    The new score means Repligen is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. 
    Via Investor's Business Daily
    Exposures COVID-19
    Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript
    RGEN earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Dow Jones Hits High As Metals, Miners, Fertilizers Thrive, But Growth Stocks Slump; Jobs Report Stunningly Weak
    The Dow hit highs but growth stocks slumped, despite a Friday bounce on weak jobs gains. Miners, metals, fertilizers thrived. 
    Via Investor's Business Daily
    Topics Economy Intellectual Property Stocks
    Exposures COVID-19 Intellectual Property Interest Rates
    Repligen Earnings Double As Sales Growth Accelerates; RGEN Stock Nears Buy Point
    Repligen earnings shot up 113% in Q1 with sales growth accelerating to 88%. The biotech raised full-year guidance. RGEN stock rose, nearing a buy point. 
    Via Investor's Business Daily
    Repligen: Q1 Earnings Insights
    Shares of Repligen (NASDAQ:RGEN) moved higher by 7.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 112.50% over... 
    Via Benzinga
    The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... 
    Via Benzinga
    Earnings Scheduled For May 4, 2021
    Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.